Long-Lived Plasma Cells Are Contained within the CD19-CD38hiCD138+ Subset in Human Bone Marrow

Immunity

Volumn 43, Issue 1, 2015, Pages 132-145

  Halliley, Jessica L ^a,b   Tipton, Christopher M ^a   Liesveld, Jane ^b   Rosenberg, Alexander F ^b   Darce, Jaime ^c   Gregoretti, Ivan V ^c   Popova, Lana ^c   Kaminiski, Denise ^b   Fucile, Christopher F ^b   Albizua, Igor ^a   Kyu, Shuya ^a   Chiang, Kuang Yueh ^d   Bradley, Kyle T ^d   Burack, Richard ^b   Slifka, Mark ^e   Hammarlund, Erika ^e   Wu, Hao ^a   Zhao, Liping ^a   Walsh, Edward E ^b   Falsey, Ann R ^b   Randall, Troy D ^f   Cheung, Wan Cheung ^c,g   Sanz, Iñaki ^a   Lee, F Eun Hyung ^a   more..

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CELL SIGNALING TECHNOLOGY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f The University of Alabama at Birmingham   (United States)

^g PFIZER INC   (United States)

Author keywords

Antibody secreting cells; Bone marrow; Heterogeneity; Human; Long lived plasma cells; Measles; Mumps infection; Next generation sequencing; Plasma cells; Plasmablasts; Proteomics; Vaccine

Indexed keywords

ANTIBODY; CD19 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INFLUENZA VACCINE; MEASLES ANTIBODY; MUMPS SPECIFIC CIRCULATING ANTIBODY; SYNDECAN 1; TETANUS TOXOID; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS ANTIGEN; CD38 PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; SDC1 PROTEIN, HUMAN; VIRUS ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFLUENZA; INFLUENZA VACCINATION; MALE; MEASLES VACCINATION; NORMAL HUMAN; PRIORITY JOURNAL; BLOOD; GENETICS; IMMUNOLOGY; MEASLES VIRUS; METABOLISM; MIDDLE AGED; MUMPS VIRUS; PLASMA CELL; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, CD19; ANTIGENS, CD38; BONE MARROW CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUMPS VIRUS; PLASMA CELLS; RNA, MESSENGER; SYNDECAN-1; YOUNG ADULT;

EID: 84937714861     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.06.016     Document Type: Article

References (50)

1. Ahuja A., Anderson S.M., Khalil A., Shlomchik M.J. Maintenance of the plasma cell pool is independent of memory B cells. Proc. Natl. Acad. Sci. USA 2008, 105:4802-4807.
2. Alamyar E., Giudicelli V., Li S., Duroux P., Lefranc M.P. IMGT/HighV-QUEST: the IMGT(R) web portal for immunoglobulin (IG) or antibody and Tcell receptor (TR) analysis from NGS high throughput and deep sequencing. Immunome Res. 2012, 8:26.
3. Amanna I.J., Slifka M.K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 2010, 236:125-138.
4. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N.Engl. J. Med. 2007, 357:1903-1915.
5. Avery D.T., Ellyard J.I., Mackay F., Corcoran L.M., Hodgkin P.D., Tangye S.G. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J.Immunol. 2005, 174:4034-4042.
6. Benson M.J., Dillon S.R., Castigli E., Geha R.S., Xu S., Lam K.P., Noelle R.J. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J.Immunol. 2008, 180:3655-3659.
7. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
8. Cambridge G., Leandro M.J., Teodorescu M., Manson J., Rahman A., Isenberg D.A., Edwards J.C. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum. 2006, 54:3612-3622.
9. Cassese G., Arce S., Hauser A.E., Lehnert K., Moewes B., Mostarac M., Muehlinghaus G., Szyska M., Radbruch A., Manz R.A. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J.Immunol. 2003, 171:1684-1690.
10. Cheung W.C., Beausoleil S.A., Zhang X., Sato S., Schieferl S.M., Wieler J.S., Beaudet J.G., Ramenani R.K., Popova L., Comb M.J., et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat. Biotechnol. 2012, 30:447-452.
11. Fairfax K.A., Kallies A., Nutt S.L., Tarlinton D.M. Plasma cell development: from B-cell subsets to long-term survival niches. Semin. Immunol. 2008, 20:49-58.
12. González-García I., Ocaña E., Jiménez-Gómez G., Campos-Caro A., Brieva J.A. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J.Immunol. 2006, 176:4042-4050.
13. González-García I., Rodríguez-Bayona B., Mora-López F., Campos-Caro A., Brieva J.A. Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood 2008, 111:741-749.
14. Halliley J.L., Kyu S., Kobie J.J., Walsh E.E., Falsey A.R., Randall T.D., Treanor J., Feng C., Sanz I., Lee F.E. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010, 28:3582-3587.
15. Hargreaves D.C., Hyman P.L., Lu T.T., Ngo V.N., Bidgol A., Suzuki G., Zou Y.R., Littman D.R., Cyster J.G. A coordinated change in chemokine responsiveness guides plasma cell movements. J.Exp. Med. 2001, 194:45-56.
16. Hauser A.E., Debes G.F., Arce S., Cassese G., Hamann A., Radbruch A., Manz R.A. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J.Immunol. 2002, 169:1277-1282.
17. Hilbert D.M., Kopf M., Mock B.A., Köhler G., Rudikoff S. Interleukin 6 is essential for invivo development of B lineage neoplasms. J.Exp. Med. 1995, 182:243-248.
18. Huggins J., Pellegrin T., Felgar R.E., Wei C., Brown M., Zheng B., Milner E.C., Bernstein S.H., Sanz I., Zand M.S. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007, 109:1611-1619.
19. Jourdan M., Caraux A., Caron G., Robert N., Fiol G., Rème T., Bolloré K., Vendrell J.P., Le Gallou S., Mourcin F., et al. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J.Immunol. 2011, 187:3931-3941.
20. Kaminski D.A., Lee F.E. Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design. Front. Immunol. 2011, 2:76.
21. Kelly D.F., Snape M.D., Clutterbuck E.A., Green S., Snowden C., Diggle L., Yu L.M., Borkowski A., Moxon E.R., Pollard A.J. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006, 108:2642-2647.
22. Krzywinski M., Schein J., Birol I., Connors J., Gascoyne R., Horsman D., Jones S.J., Marra M.A. Circos: an information aesthetic for comparative genomics. Genome Res. 2009, 19:1639-1645.
23. Kyu S.Y., Kobie J., Yang H., Zand M.S., Topham D.J., Quataert S.A., Sanz I., Lee F.E. Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J.Immunol. Methods 2009, 340:42-47.
24. Lee F.E., Halliley J.L., Walsh E.E., Moscatiello A.P., Kmush B.L., Falsey A.R., Randall T.D., Kaminiski D.A., Miller R.K., Sanz I. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J.Immunol. 2011, 186:5514-5521.
25. Liu D., Lin P., Hu Y., Zhou Y., Tang G., Powers L., Medeiros L.J., Jorgensen J.L., Wang S.A. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma. J.Clin. Pathol. 2012, 65:823-829.
26. Macallan D.C., Wallace D.L., Zhang Y., Ghattas H., Asquith B., de Lara C., Worth A., Panayiotakopoulos G., Griffin G.E., Tough D.F., Beverley P.C. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 2005, 105:3633-3640.
27. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
28. McMillan R., Longmire R.L., Yelenosky R., Lang J.E., Heath V., Craddock C.G. Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. J.Immunol. 1972, 109:1386-1394.
29. Medina F., Segundo C., Campos-Caro A., González-García I., Brieva J.A. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002, 99:2154-2161.
30. Mei H.E., Wirries I., Frölich D., Brisslert M., Giesecke C., Grün J.R., Alexander T., Schmidt S., Luda K., Kühl A.A., et al. A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow. Blood 2015, 125:1739-1748.
31. Miller F.R. The induced development and histogenesis of plasma cells. J.Exp. Med. 1931, 54:333-347.
32. Morell A., Terry W.D., Waldmann T.A. Metabolic properties of IgG subclasses in man. J.Clin. Invest. 1970, 49:673-680.
33. Nie Y., Waite J., Brewer F., Sunshine M.J., Littman D.R., Zou Y.R. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J.Exp. Med. 2004, 200:1145-1156.
34. Odendahl M., Mei H., Hoyer B.F., Jacobi A.M., Hansen A., Muehlinghaus G., Berek C., Hiepe F., Manz R., Radbruch A., Dörner T. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005, 105:1614-1621.
35. Oracki S.A., Walker J.A., Hibbs M.L., Corcoran L.M., Tarlinton D.M. Plasma cell development and survival. Immunol. Rev. 2010, 237:140-159.
36. Palese P.S., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, 1647-1689. Lippincott Williams& Wilkins, Philadelphia. D.H. Knipe, P.M. Howley (Eds.).
37. Pengo N., Scolari M., Oliva L., Milan E., Mainoldi F., Raimondi A., Fagioli C., Merlini A., Mariani E., Pasqualetto E., et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 2013, 14:298-305.
38. Qian Y., Wei C., Eun-Hyung Lee F., Campbell J., Halliley J., Lee J.A., Cai J., Kong Y.M., Sadat E., Thomson E., et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 2010, 78(Suppl 1):S69-S82.
39. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dörner T., Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006, 6:741-750.
40. Rawstron A.C., Davies F.E., DasGupta R., Ashcroft A.J., Patmore R., Drayson M.T., Owen R.G., Jack A.S., Child J.A., Morgan G.J. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 2002, 100:3095-3100.
41. Rozanski C.H., Arens R., Carlson L.M., Nair J., Boise L.H., Chanan-Khan A.A., Schoenberger S.P., Lee K.P. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J.Exp. Med. 2011, 208:1435-1446.
42. Sato S., Beausoleil S.A., Popova L., Beaudet J.G., Ramenani R.K., Zhang X., Wieler J.S., Schieferl S.M., Cheung W.C., Polakiewicz R.D. Proteomics-directed cloning of circulating antiviral human monoclonal antibodies. Nat. Biotechnol. 2012, 30:1039-1043.
43. Skowronski D.M., Tweed S.A., De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J.Infect. Dis. 2008, 197:490-502.
44. Slifka M.K., Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 1998, 10:252-258.
45. Storey J.D. A direct approach to false discovery rates. J.R. Stat. Soc., B 2002, 64:479-498.
46. Tourigny M.R., Ursini-Siegel J., Lee H., Toellner K.M., Cunningham A.F., Franklin D.S., Ely S., Chen M., Qin X.F., Xiong Y., et al. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity 2002, 17:179-189.
47. Turner C.A., Mack D.H., Davis M.M. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994, 77:297-306.
48. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
49. Xiang Z., Cutler A.J., Brownlie R.J., Fairfax K., Lawlor K.E., Severinson E., Walker E.U., Manz R.A., Tarlinton D.M., Smith K.G. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 2007, 8:419-429.
50. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., Tumpey T.M., Pappas C., Perrone L.A., Martinez O., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536.